Premium

SRK, Ajay Devgn get notice: Prahlad Kakar explains how, why surrogate ads work

Veteran ad filmmaker Prahlad Kakar explains why surrogate advertising thrives in the grey areas of regulation and how brands stay aspirational and culturally relevant without showing the prohibited product.

Shah Rukh Khan (left) and Ajay Devgan (right) have been issued notices for their Vimal Elaichi ad by Maharashtra's FDA (Wikimedia Images)Shah Rukh Khan (left) and Ajay Devgan (right) have been issued notices for their Vimal Elaichi ad by Maharashtra's FDA (Wikimedia Images)
Written by: Rinku Ghosh
6 min readNew DelhiAug 25, 2026 05:43 PM IST First published on: Aug 25, 2026 at 03:30 PM IST

The Maharashtra Food and Drug Administration’s (FDA) recent action against actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff has brought an old advertising problem back into sharp focus: when does a legal brand extension become a surrogate for a prohibited product?

The FDA issued show-cause notices to the three actors over a Vimal Elaichi advertisement, alleging that the campaign creates an association with Vimal Pan Masala, which is prohibited in Maharashtra.

Advertisement

Surrogate advertising has long worked by shifting the conversation away from the restricted product and towards the lifestyle, aspiration and cultural world surrounding the brand. As the advertising industry itself has evolved, that strategy has moved from club soda and music CDs to festivals, sponsorships, social media and celebrity partnerships. The product may disappear from the frame; the brand, however, remains firmly in the consumer’s mind.

Rinku Ghosh is the Health Section Lead at Read More

Latest Comment
Post Comment
Read Comments